We are live on ! Find out more
PIM

Ponoi II Management Portfolio holdings

AUM $38.3M
1-Year Est. Return 32.02%
This Fund
S&P 500
This Quarter Est. Return
+6.54%
1 Year Est. Return
-32.02%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$123M
AUM Growth
-$7.18M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNST
1
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$53.2M 43.12%
1,574,229
NGM
2
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$25.6M 20.76%
1,298,908
RVMD icon
3
Revolution Medicines
RVMD
$39.6B
$21.7M 17.62%
685,011
NRIX icon
4
Nurix Therapeutics
NRIX
$2.4B
$18.2M 14.76%
686,274
RAPT
5
DELISTED
RAPT Therapeutics
RAPT
$4.62M 3.75%
18,175

Similar funds

Ponoi II Management's Q2 2021 Portfolio in Review

As of Q2 2021, Ponoi II Management held 5 positions worth $123M, down 5.5% from $131M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2021: portfolio turnover was 0%. Ponoi II Management opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Ponoi II Management's ten largest holdings make up 100% of its $123M portfolio in Q2 2021.
  • Ponoi II Management opened 0 new positions and closed 0 in Q2 2021.
  • Ponoi II Management's portfolio value fell 5.5% quarter-over-quarter to $123M.

Based on Ponoi II Management's 13F filing for Q2 2021, filed 16 Aug 2021.